期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 106, 期 -, 页码 287-293出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2017.05.062
关键词
Small interfering RNA; Magnetic siRNA nanovectors (MSN); Superparamagnetic iron oxide nanoparticles (SPION); Capillary electrophoresis (CE); Purification
资金
- Institut National du Cancer (INCa)
- Fondation ARC
- Ligue nationale contre le cancer (LNCC) [ARC_INCa_LNCC_7636]
Gene therapy and particularly small interfering RNA (siRNA) is a promising therapeutic method for treatment of various human diseases, especially cancer. However the lack of an ideal delivery system limits its clinical applications. Effective anticancer drug development represents the key for translation of research advances into medicines. Previously we reported, the optimization of magnetic siRNA nanovectors (MSN) formulation based on superparamagnetic iron oxide nanoparticles (SPION) and chitosan for systemic administration. This work aimed at using rational design to further optimize and develop MSN. Therefore, formulated MSN were first purified, then their physical and chemical properties were studied mainly through capillary electrophoresis. 95% of siRNA was found enclosed within the purified MSN (pMSN). pMSN showed colloidal stability at pH 7.4, effective protection of siRNA against ribonuclease degradation up to 24 hours and few siRNA release (less than 10%) at pH 7.4. These findings push toward further evaluation studies in vitro and/or in vivo, indicating the appropriateness of pMSN for cancer theranostics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据